Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Assessment of the Efficacy of Atrantil In the Treatment of Methane-Predominate Intestinal Bacterial Overgrowth

NCT04755673 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04755673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04755673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Assessment of the Efficacy of Atrantil In the Treatment of Methane-Predominate Intestinal Bacterial Overgrowth
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Completed
Start date
September 18, 2020
Completion date
September 27, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial overgrowth syndrome, irritable bowel syndrome, sibo